Breast Milk News and Research RSS Feed - Breast Milk News and Research

Women taking tacrolimus drug can breast feed their babies

Women taking tacrolimus drug can breast feed their babies

Women taking the immunosuppressant tacrolimus can rest assured that breast feeding will not elevate their babies' exposure to the drug, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN). [More]

Concern over privacy in neonatal intensive care units

Researchers say that privacy is a problem for breastfeeding mothers of newborns in the neonatal intensive care unit. [More]
FDA approves Allergan’s BOTOX to treat overactive bladder

FDA approves Allergan’s BOTOX to treat overactive bladder

Allergan, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved BOTOX (onabotulinumtoxinA) for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and frequency in adults who have had an inadequate response to or are intolerant of an anticholinergic medication. [More]
Many mothers of newborns in NICUs lack privacy to breastfeed

Many mothers of newborns in NICUs lack privacy to breastfeed

Many mothers of newborns in neonatal intensive care units have difficulty finding private, quiet places in the hospital to express milk, according to a new study from the Frances Payne Bolton School of Nursing at Case Western Reserve University. [More]
Pfizer’s Quillivant XR now available in the U.S. for treatment of ADHD

Pfizer’s Quillivant XR now available in the U.S. for treatment of ADHD

Pfizer Inc. today announced that Quillivant XR (methylphenidate hydrochloride) CII for extended-release oral suspension is now available in the U.S. for the treatment of attention deficit hyperactivity disorder (ADHD). [More]
Glycan released by parasites might help treat metabolic disorders associated with obesity

Glycan released by parasites might help treat metabolic disorders associated with obesity

On the list of undesirable medical conditions, a parasitic worm infection surely ranks fairly high. Although modern pharmaceuticals have made them less of a threat in some areas, these organisms are still a major cause of disease and disability throughout much of the developing world. [More]
Study reveals large microbial diversity in breast milk

Study reveals large microbial diversity in breast milk

Spanish researchers have traced the bacterial microbiota map in breast milk, which is the main source of nourishment for newborns. The study has revealed a larger microbial diversity than originally thought: more than 700 species. [More]
Breast milk banks: an interview with Dr. Pieter Koorts

Breast milk banks: an interview with Dr. Pieter Koorts

The available literature clearly demonstrates that in almost all circumstances a mother’s own breast milk is the ideal food for her infant. This is particularly important for preterm infants. Preterm infants are babies born before 37 completed weeks of pregnancy. [More]
Study identifies risk factors associated with co-exposure to lead, mercury and PCBs

Study identifies risk factors associated with co-exposure to lead, mercury and PCBs

Nearly 23 percent of American women of childbearing age met or exceeded the median blood levels for all three environmental chemical pollutants - lead, mercury, and PCBs - tracked in an analysis of data on thousands of women by Brown University researchers. [More]
Omega-3 fatty acids can benefit women at risk of postpartum depression

Omega-3 fatty acids can benefit women at risk of postpartum depression

The "feel-good" hormone serotonin, depleted by pregnancy, can be replenished by adding sources of omega-3 to the diets of pregnant women and new mothers - a development particularly beneficial to the 10 to 15 percent of women at risk for postpartum depression, according to a recent University of Montreal study published in the latest edition of the Canadian Journal of Psychiatry. [More]
Pfizer completes acquisition of NextWave Pharmaceuticals

Pfizer completes acquisition of NextWave Pharmaceuticals

Pfizer Inc. today announced that it has completed its acquisition of NextWave Pharmaceuticals, Inc., a privately held, specialty pharmaceutical company focused on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder (ADHD). [More]

Study indicates that Firemaster 550 is an endocrine disruptor

The flame-retardant mixture known as "Firemaster 550" is an endocrine disruptor that causes extreme weight gain, early onset of puberty and cardiovascular health effects in lab animals, according to a new study spearheaded by researchers from North Carolina State University and Duke University. [More]

Pfizer announces intention to acquire NextWave

Pfizer Inc. today announced its intention to acquire NextWave Pharmaceuticals, a privately held, specialty pharmaceutical company focused on the development and commercialization of unique products for the treatment of attention deficit/hyperactivity disorder (ADHD) and related central nervous system (CNS) disorders. [More]
Study identifies critical contributors of pediatric acute lymphoblastic leukemia

Study identifies critical contributors of pediatric acute lymphoblastic leukemia

Results of one study indicate that the risk for developing pediatric acute lymphoblastic leukemia increased the longer a baby was fed formula and the longer solid foods were delayed. [More]
Newborn mice use mum's unique odour to begin breastfeeding

Newborn mice use mum's unique odour to begin breastfeeding

Researchers show for the first time that a mammal begins to suckle its mother's milk through a learned response built on learning her unique combination of smells. When it is born, the newborn is exposed to the smell of its mother's amniotic fluid and the baby then responds to those smells to feed. [More]
FDA approves Stiefel’s Sorilux Foam sNDA to treat for scalp psoriasis

FDA approves Stiefel’s Sorilux Foam sNDA to treat for scalp psoriasis

Stiefel, a GSK company, today announced that the US Food and Drug Administration has approved a supplemental New Drug Application (sNDA) for Sorilux (calcipotriene) Foam, 0.005%. The sNDA expands the indication for Sorilux Foam to include the topical treatment of plaque psoriasis of the scalp in patients aged 18 years and older. [More]
Concentrated high-protein liquid fortifier boosts ICU babies’ growth

Concentrated high-protein liquid fortifier boosts ICU babies’ growth

Breast milk fortified with an ultraconcentrated high-protein liquid increases growth and is well-tolerated by preterm babies in comparison with a lower-protein enriched powder alternative, research shows. [More]
Lilly, Boehringer Ingelheim announce availability of My Well Planner for adults with type 2 diabetes

Lilly, Boehringer Ingelheim announce availability of My Well Planner for adults with type 2 diabetes

Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announce the availability of a new online program offering customized educational content to help adults with type 2 diabetes make simple lifestyle changes to improve their health. [More]
Infants’ oral microbiota differs according to feeding method

Infants’ oral microbiota differs according to feeding method

The oral microbiota of 3-month old infants is distinguishable by whether they are breast- or formula-fed, show study findings. [More]
U of I microbial engineer synthesizes 2-fucosyllactose to protect babies from pathogens

U of I microbial engineer synthesizes 2-fucosyllactose to protect babies from pathogens

A University of Illinois microbial engineer has synthesized a sugar in human milk that is thought to protect babies from pathogens. That's important because 2FL, the shorthand scientists use to describe this human milk oligosaccharide (HMO), has not been added to infant formula because HMOs are incredibly expensive. [More]